Emergent BioSolutions Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on March 08, 2012, covering an event that occurred on March 03, 2012. Emergent BioSolutions Inc. is a Delaware corporation headquartered in Rockville, Maryland.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on a specific lease agreement amendment.
Material Changes
On March 03, 2012, the Company entered into a third amendment to its lease with Brandywine Research LLC for its headquarters at 2273 Research Boulevard, Rockville, Maryland.
- Space Expansion: The leased premises increased by approximately 8,000 square feet, adding to the existing 33,000 square feet.
- Lease Term: The expiration date remains unchanged at December 31, 2016.
- Rent Concessions: Rent for the additional 8,000 square feet is waived for approximately six months.
- Future Rent Obligations: Monthly basic rent for the expansion premises is scheduled as follows:
- $18,245 (Sept 1, 2012 - Feb 28, 2013)
- $18,745 (Mar 1, 2013 - Feb 28, 2014)
- $19,266 (Mar 1, 2014 - Feb 28, 2015)
- $19,793 (Mar 1, 2015 - Feb 29, 2016)
- $20,333 (Mar 1, 2016 - Dec 31, 2016)
Guidance, Outlook, and Risks
The filing contains no management guidance, outlook, or discussion of risks beyond the standard qualification that the summary is subject to the full terms of the Lease Amendment. The full agreement is intended to be filed as an exhibit to the Annual Report on Form 10-K for the year ended December 31, 2011.
Key Facts for Investor Verification
- Verify the total square footage of the new lease (approx. 41,000 sq. ft.) against the company's operational capacity needs.
- Confirm the total financial impact of the rent escalation schedule over the remaining lease term.
- Review the full Lease Amendment exhibit in the upcoming Form 10-K for any covenants or termination clauses not summarized here.